ceftazidime-avibactam
Jump to navigation
Jump to search
Indications
- complicated urinary tract infections
- multidrug-resitant Klebsiella pneumoniae resistant to
- carbepenem-resistant Enterobacterales[2][3]
- complicated intra-abdominal infections
More general terms
Components
References
- ↑ Zuger A The Newest Antibiotics on the Block. NEJM Journal Watch. June 13, 2016 Massachusetts Medical Society (subscription needed) http://www.jwatch.org
Deak D et al. Progress in the fight against multidrug-resistant bacteria? A review of U.S. Food and Drug Administration-approved antibiotics, 2010-2015. Ann Intern Med 2016 May 31 PMID: https://www.ncbi.nlm.nih.gov/pubmed/27239977 - ↑ Jump up to: 2.0 2.1 Medical Knowledge Self Assessment Program (MKSAP) 20 American College of Physicians, Philadelphia 2025
- ↑ Jump up to: 3.0 3.1 Tompkins K, van Duin D. Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions. Eur J Clin Microbiol Infect Dis. 2021;40:2053-2068. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34169446